Periarthritis of shoulder
Conditions
Interventions
Control group:Loxoprofen sodium gel plaster was applied topically to the pain site once a day, 1 patch/site/time
Research Group:Topical ketoprofen gel plaster was applied to the pain site, 2 times/day, 1 patch/site/time
Sponsors
The Second Hospital of Shanxi Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.For outpatients or inpatients with a history of recurrent scapulohumeral periarthritis, unilateral scapulohumeral periarthritis or bilateral scapulohumeral periarthritis occurs on the more severe side; 2.Patients with painful scapulohumeral periarthritis (duration =4 points; 5.All subjects voluntarily agreed to participate in the study and signed a written informed consent.
Exclusion criteria
Exclusion criteria: 1.Hormone injection within 4 weeks before enrollment; Patients had taken systemic NSAIDs within 2 weeks after enrollment and topical NSAIDs within 1 week before enrollment. 2.Patients with acute soft tissue injury, infectious inflammation, fracture, dislocation, rheumatoid arthritis of the shoulder; 3.Shoulder radiating pain or movement disorder caused by non-scapulohumeral periarthritis (such as cervical spondylosis, rotator cuff injury, subacromial impingement, lung cancer, cholecystitis, angina pectoris, myocardial infarction, etc.); 4.Patients with diabetes mellitus should meet the following criteria: glycosylated hemoglobin 3 times the upper limit, Cr > 1.5 times the upper limit), active gastrointestinal ulcer or bleeding history; 6.Patients with a history of allergy to NSAIDs or the study drug paste; People with allergies (such as those with chronic urticaria), who have skin damage, eczema, dermatitis or infection in the affected area; 7.Pregnant and lactating women and those with mental disorders who could not cooperate with the follow-up assessment; 8.If the investigator considers that it is not appropriate to participate in the trial, such as participating in other clinical trials;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale (VAS) score;Constant-Murley score for shoulder joint function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment; | — |
Countries
China
Contacts
Public ContactZhang Min
The Second Hospital of Shanxi Medical University
Outcome results
None listed